APACHEⅡ评分对AECOPD患者预后的应用价值

目的：探讨慢性阻塞性肺疾病急性发作期（AECOPD）患者预后与急性生理学与慢性健康状况评分Ⅱ（acute physiology and chronic health evaluation，APACHEⅡ）评分的关系。方法：收集本院82例AECOPD患者的临床资料，计算APACHEⅡ分值，观察不同APACHEⅡ分值患者的插管率和病死率。结果：APACHEⅡ〈10分组插管率为8．33％，病死率为8．33％；10～19分组插管率为15．63％，病死率为25．00％；20～29分组插管率为33．33％，病死率为44．44％；≥30分组插管率为60．00％，病死率为70．00％，4组插管率和病死率差异有统计学意义，P〈0．01。结论：APACHEⅡ评分可以用来预测慢性阻塞性肺疾病急性加重期患者的预后。

The application value of prognosis about APACHEII in AECOPD patient

Objective： To investigate the relationship between APACHE Ⅱ and the prognosis of AECOPD patient. Methods： The clinic data of 82 AECOPD patients in the respiratory department of our hospital were collected.Compute the score of APACHE Ⅱ, the moralities and intubation in different APACHE Ⅱ scores were compared. Results： The intubation in APACHE Ⅱ 〈10 grouping intubation rate for 8.33%, fatality rate was 8.33%; 10 to 19 grouping was 15.63%, fatality rate was 25.00%; 20 to 29 grouping intubation rate was 33.33%, fatality rate was 44.44%; ≥30 grouping intubation was 60.00%, fatality rate was 70.00%, 4 groups for mortality rate and mortality intubated was statistically significant difference （P〈0.01）. Conclusion： The study shows that APACHE Ⅱ score is applicable to estimate the prognosis of AECOPD patients.